Institute for Clinical and Economic Review’s New Evidence Update on PCSK9 Inhibitors Delayed

ICER will be delaying the release of the New Evidence Update on PCSK9 inhibitors while our analyses undergo peer-review. We expect to provide an update regarding the release date by May 31st.

For more information about the update, please see our press release. More information about the updated timeline will be posted to our website as it becomes available.